NCT02708056已完成4 期
Sugammadex Given for the Reversal of Deep Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants: A Retrospective Study
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 26
- 主要终点
- The efficacy of sugammadex were assessed by using Train of four (TOF)
研究概览
简要总结
The objective of this study is to evaluate the efficacy and safety of sugammadex in reversing profound neuromuscular block induced by rocuronium in infant patients
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 1 Month 至 12 Months(Child)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients between the ages of 1-12 month,
- •ASA physical status 1-3 who underwent elective brain cancer surgery during general anesthesia were included in the study
排除标准
- •younger than 1month or older than 12 months.
- •hepatic or renal failure
- •A history of allergy to study medication
研究组 & 干预措施
Sugammadex, Bridion
Other
Drug were given intravenously by a anesthesiologist at the end of surgery
干预措施: Sugammadex (Drug)
结局指标
主要结局
The efficacy of sugammadex were assessed by using Train of four (TOF)
时间窗: 1 year
次要结局
未报告次要终点
研究者
Ozlem Ozmete
Medical Doctor
Baskent University
相似试验
Unknown
4 期
Pharmacokinetics of Sugammadex for the Reversal of Moderate Neuromuscular Blockade in Patients During Renal TransplantationPharmacokineticsNCT05187455Guangzhou General Hospital of Guangzhou Military Command34
已完成
4 期
Sugammadex Titration in Cardiac Surgery PatientsValvular Heart DiseaseAorta DiseaseHeart FailureCoronary Artery DiseaseNCT05246397University of Washington100
已完成
4 期
Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting SurgerySurgeryCoronary Artery DiseaseNCT03939923West Virginia University84
已完成
4 期
Sugammadex Versus Neostigmine for Reversal of Rocuronium NeuromuscularNeuromuscular BlockadeAnesthesiaNCT03322657The Cleveland Clinic69
尚未招募
4 期
A clinical trial to compare the effectiveness of two drugs (sugammadex vs neostigmine-glycopyrolate)in patient undergoing cardiac surgeries.CTRI/2024/08/072509Vignesh D
